Peiser Leanne, Makepeace Katherine, Plüddemann Annette, Savino Silvana, Wright J Claire, Pizza Mariagrazia, Rappuoli Rino, Moxon E Richard, Gordon Siamon
Sir William Dunn School of Pathology, South Parks Road, Oxford OX1 3RE, United Kingdom.
Infect Immun. 2006 Sep;74(9):5191-9. doi: 10.1128/IAI.00124-06.
Macrophages (Mphi) may play an important role in the pathogenesis of invasive meningococcal infection. Previously, we have shown that the class A Mphi scavenger receptor (SR-A) is a major nonopsonic receptor for Neisseria meningitidis on Mphi. SR-A contributes to host defense by binding proinflammatory polyanionic ligands such as lipopolysaccharide (LPS) and by the uptake and killing of live organisms. SR-A-deficient mouse Mphi display a substantial reduction in the number of meningococci ingested compared to wild-type Mphi, and SR-A is required for meningococcal phagocytosis but not for the release of tumor necrosis factor alpha. Although soluble lipid A and lipid(IV)A are reported as ligands for SR-A, we demonstrated that LPS and LPS expression were not essential for the uptake of whole meningococci. In the present study, we set out to discover protein ligand(s) for SR-A in N. meningitidis lysates and outer membrane vesicles. Using various microbial mutant strains, we determined that molecules comprising the membrane capsule and pili, as well as the abundant surface Opa proteins were not essential for SR-A recognition. We developed a binding assay to detect SR-A ligands and identified three candidate proteins expressed on intact organisms, namely, NMB1220, NMB0278, and NMB0667. Soluble forms of these ligands were shown to block the binding of meningococci to CHO cells stably transfected with SR-A. Furthermore, NMB1220 was endocytosed by SR-A on Mphi and prevented internalization of soluble acetylated low-density lipoprotein. Thus, we have identified novel, unmodified protein ligands for SR-A that are able to inhibit meningococcal interactions with macrophages in vitro.
巨噬细胞(Mphi)可能在侵袭性脑膜炎球菌感染的发病机制中起重要作用。此前,我们已经表明,A类Mphi清道夫受体(SR-A)是脑膜炎奈瑟菌在Mphi上的主要非调理素受体。SR-A通过结合促炎多阴离子配体(如脂多糖(LPS))以及摄取和杀死活生物体来促进宿主防御。与野生型Mphi相比,缺乏SR-A的小鼠Mphi摄取的脑膜炎球菌数量大幅减少,脑膜炎球菌的吞噬作用需要SR-A,但肿瘤坏死因子α的释放则不需要。尽管可溶性脂质A和脂质(IV)A被报道为SR-A的配体,但我们证明LPS和LPS表达对于摄取完整的脑膜炎球菌并非必不可少。在本研究中,我们着手在脑膜炎奈瑟菌裂解物和外膜囊泡中发现SR-A的蛋白质配体。使用各种微生物突变株,我们确定构成膜荚膜和菌毛的分子以及丰富的表面Opa蛋白对于SR-A识别并非必不可少。我们开发了一种结合测定法来检测SR-A配体,并鉴定了完整生物体上表达的三种候选蛋白,即NMB1220、NMB0278和NMB0667。这些配体的可溶性形式被证明可以阻断脑膜炎球菌与稳定转染SR-A的CHO细胞的结合。此外,NMB1220被Mphi上的SR-A内吞,并阻止可溶性乙酰化低密度脂蛋白的内化。因此,我们已经鉴定出SR-A的新型未修饰蛋白配体,它们能够在体外抑制脑膜炎球菌与巨噬细胞的相互作用。